global messaging alerts

Meet the BD Team

Meet the ApiJect Business Development Team

Our Approach

At ApiJect, our Business Development team partners with you to provide a turnkey combination product development through commercial manufacturing solution using our single-use blow-fill-seal injection platform.  We work with you to identify the appropriate injector device design, ensure ensure feasibility and identify a manufacturing solution that best fits your injectable or vaccine needs.

Bo Kowalczyk, Chief Commercial Officer

Prior to joining ApiJect, Bo served as the Vice President of Sales, North America, for Syngene International’s Chemical Development and Manufacturing division, where he aligned operational expertise with prospecting efforts to target the right opportunities and maximize client satisfaction.

Bo served as Global VP, Business Development and Marketing with Eurofins Biologics Bioanalytical Services where he led efforts to integrate Bioanalytical Services with Eurofins Central Lab Services to provide seamless services for clinical trial logistics and sample testing support. He served as Vice President, Business Development and Marketing at AIT Bioscience where he successfully grew sales & profitability over a 5- year period in part by creating a network of third-party preclinical toxicology service providers allowing AIT Bioscience earlier access to promising therapeutic candidates moving into clinical trials.

Cindy Benedict, Executive Director, Business Development

Cindy has been active in pharmaceutical business development and licensing for more than a decade.  During her tenure, she has closed licensing, development, merger, and acquisition and authorized generic deals; and led various cross-functional due diligence activities.

Prior to joining ApiJect, Cindy was the Director, Business Development & Licensing, at Midas Pharmaceuticals, where she identified and negotiated business development opportunities and transactions for the North American market. She has secured Business Development positions at Amneal Pharmaceuticals, Sandoz and CorePharma (Impax/Amneal) with a strong focus on generic pharmaceuticals and 505b2 opportunities.  Additionally, she held Clinical Supply Chain and Manufacturing positions at ImClone Systems (Lilly).

Additional Technical Resources

Social media & sharing icons powered by UltimatelySocial